Application 050585
- Type
- NDA
- Sponsor
- HOFFMANN LA ROCHE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ROCEPHIN | CEFTRIAXONE SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | ROCEPHIN | CEFTRIAXONE SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | ROCEPHIN | CEFTRIAXONE SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | ROCEPHIN | CEFTRIAXONE SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 005 | ROCEPHIN | CEFTRIAXONE SODIUM | INJECTABLE;INJECTION | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 006 | ROCEPHIN KIT | CEFTRIAXONE SODIUM; LIDOCAINE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL,N/A;N/A,1% | No | No |
| 007 | ROCEPHIN KIT | CEFTRIAXONE SODIUM; LIDOCAINE | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL,N/A;N/A,1% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050585-001 | ROCEPHIN | CEFTRIAXONE SODIUM | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | |
| N050585-002 | ROCEPHIN | CEFTRIAXONE SODIUM | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | |
| N050585-003 | ROCEPHIN | CEFTRIAXONE SODIUM | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | |
| N050585-004 | ROCEPHIN | CEFTRIAXONE SODIUM | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | |
| N050585-005 | ROCEPHIN | CEFTRIAXONE SODIUM | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | |
| N050585-006 | ROCEPHIN KIT | CEFTRIAXONE SODIUM; LIDOCAINE | EQ 1GM BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | ||
| N050585-007 | ROCEPHIN KIT | CEFTRIAXONE SODIUM; LIDOCAINE | EQ 500MG BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050585-001 | ROCEPHIN | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050585-002 | ROCEPHIN | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050585-003 | ROCEPHIN | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050585-004 | ROCEPHIN | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050585-005 | ROCEPHIN | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050585-006 | ROCEPHIN KIT | EQ 1GM BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N050585-007 | ROCEPHIN KIT | EQ 500MG BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N050585-001 | ROCEPHIN | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050585-002 | ROCEPHIN | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050585-003 | ROCEPHIN | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050585-004 | ROCEPHIN | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050585-005 | ROCEPHIN | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050585-006 | ROCEPHIN KIT | EQ 1GM BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N050585-007 | ROCEPHIN KIT | EQ 500MG BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N050585-001 | ROCEPHIN | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050585-002 | ROCEPHIN | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050585-003 | ROCEPHIN | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050585-004 | ROCEPHIN | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050585-005 | ROCEPHIN | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050585-006 | ROCEPHIN KIT | EQ 1GM BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N050585-007 | ROCEPHIN KIT | EQ 500MG BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-001 | ROCEPHIN | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-002 | ROCEPHIN | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-003 | ROCEPHIN | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-004 | ROCEPHIN | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-005 | ROCEPHIN | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-006 | ROCEPHIN KIT | EQ 1GM BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050585-007 | ROCEPHIN KIT | EQ 500MG BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N050585-001 | ROCEPHIN | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050585-002 | ROCEPHIN | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050585-003 | ROCEPHIN | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050585-004 | ROCEPHIN | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050585-005 | ROCEPHIN | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050585-006 | ROCEPHIN KIT | EQ 1GM BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N050585-007 | ROCEPHIN KIT | EQ 500MG BASE/VIAL,N/A;N/A,1% | INJECTABLE / INJECTION | 1996-05-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050585-001 | ROCEPHIN | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050585-002 | ROCEPHIN | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050585-003 | ROCEPHIN | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050585-004 | ROCEPHIN | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | RLD | 1984-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050585-005 | ROCEPHIN | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1984-12-21 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | ac03a72c-0e35-40f9-b7fc-081badb5f19c | 2023-01-28 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone | CEFTRIAXONE SODIUM | Samson Medical Technologies, LLC | 5cd2d96f-83e5-4326-ae87-d0ede4ba493a | 2023-01-15 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 | 2022-10-01 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | 42ba7a9d-7d2b-4eac-af59-897151a8c924 | 2022-05-02 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 9d1f630b-e759-4395-9d01-ddc90e4fea75 | 2022-03-09 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 54905 | SUPPL | 2018-07-16 |
| 54879 | SUPPL | 2018-07-13 |
| 7848 | SUPPL | 2015-07-08 |
| 39008 | SUPPL | 2015-07-01 |
| 7847 | SUPPL | 2015-03-24 |
| 17903 | SUPPL | 2015-03-23 |
| 30121 | SUPPL | 2013-04-16 |
| 17902 | SUPPL | 2013-04-16 |
| 30118 | SUPPL | 2010-11-18 |
| 17900 | SUPPL | 2010-11-17 |
| 30120 | SUPPL | 2010-03-04 |
| 17901 | SUPPL | 2010-03-03 |
| 30119 | SUPPL | 2009-06-16 |
| 39007 | SUPPL | 2009-06-10 |
| 17899 | SUPPL | 2009-04-03 |
| 30117 | SUPPL | 2009-03-13 |
| 39003 | SUPPL | 2008-08-26 |
| 17898 | SUPPL | 2008-08-26 |
| 30116 | SUPPL | 2008-08-20 |
| 44200 | ORIG | 2007-09-11 |
| 17897 | SUPPL | 2007-07-24 |
| 7846 | SUPPL | 2007-07-24 |
| 39006 | SUPPL | 2007-05-16 |
| 30115 | SUPPL | 2007-05-16 |
| 39005 | SUPPL | 2004-09-15 |
| 30114 | SUPPL | 2004-09-15 |
| 39004 | SUPPL | 2004-09-03 |
| 30113 | SUPPL | 2004-09-03 |
| 7845 | SUPPL | 2004-04-07 |
| 17896 | SUPPL | 2004-04-05 |